CANNABIS INDUSTRY MOGULS MEET IN MIAMI FOR BENZINGA CONFERENCE
More than 100 CEOs and 200 Investors Confirmed for Cannabis Investment & Branding Conference on April 16th at The Diplomat Beach Resort in Hollywood, FL.Boris Jordan, executive chairman of Curaleaf, to Deliver Keynote Speech.
HOLLYWOOD, Fla., March 12, 2024 /PRNewswire/ -- The Benzinga Cannabis Capital Conference, North America's premier cannabis investment and branding event, is returning to Florida for a two-day conference starting on April 16, 2024, at The Diplomat Beach Resort in Hollywood. Anchored by keynote speaker Boris Jordan, the event has over 100 CEOs confirmed and is anticipating more than 2,000 attendees. As one of the most established shows in this industry, the event offers unparalleled opportunities and connections for cannabis entrepreneurs, marketers, and investors to network, learn, and grow within the industry.
This year's speakers include Canopy Growth CEO David Klein, Tahira Rehmatullah of Highlands Venture Partners, Emily Paxhia of Poseidon Asset Management, X's Alexa Alianiello, RLNTLSS BRADS' Gloria Govan, Ispire's Luna Stower, Crowe's Tiffany Richardson, Trulieve's Kim Rivers, analyst Pablo Zuanic, Wana Brads' Joe Hodas, Hara Supply's Brian Gerber, Verano's Darren Weiss and Aaron Miles, and many more.
"We have a star-studded conference lineup of active dealmakers and industry luminaries for our return to Florida," says Benzinga CEO Jason Raznick. "I predict $400M of deals will be done at this event. Our Benzinga Cannabis Capital Conference is the must-attend event of the year for anyone looking to make their mark in the cannabis world. It's the place to meet the biggest industry players and forge deals to drive the global cannabis industry forward."
Conference Highlights Include:
Exclusive Networking Opportunities: With more than 2,000 decision-makers in one room, attendees have the chance to engage in a year's worth of networking in just two days - made easy through our official Event Networking App.
Unmatched Access to Deals: From M&A beginnings to partnership formations, this conference is where the future of cannabis takes shape.
Industry-Wide Representation: With more than 90% of the publicly traded market cap in attendance, missing out means missing a crucial opportunity to participate in the industry's most significant conversations and deals.
Scholarships for Women-owned & Minority-owned Businesses: In a commitment to diversity and inclusion, Benzinga has partnered with organizations like WomenGrow and Minorities for Medical Marijuana to offer scholarships aimed at amplifying the voices of women and minority-owned businesses within the cannabis industry. This initiative seeks to showcase these businesses on conference stages and in the exhibit hall, providing a unique platform for visibility and growth.
Don't miss your chance to be part of this game-changing event. Get your tickets now atbzcannabis.com ? prices will increase soon!
About Benzinga Cannabis Capital Conference:
The Benzinga Cannabis Capital Conference is North America's leading cannabis investment and branding conference, attracting the industry's most influential figures, investors, and thought leaders. It offers an unmatched platform for networking, deal-making, and insights into the cannabis industry's future.
The Honourable Soraya Martinez Ferrada, Minister of Tourism and Minister responsible for the Economic Development Agency of Canada for the Regions of Quebec, on behalf of the Honourable François-Philippe Champagne, Minister of Innovation, Science and...
CareDx, Inc. ? The Transplant Companytm ? a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers ? today...
Marcus Powlowski, Member of Parliament for Thunder Bay-Rainy River, on behalf of the Honourable Mark Holland, Minister of Health, will hold a news conference to announce funding to improve palliative care.
There will be a media availability...
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today reported the grant of...
Syndax Pharmaceuticals , a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that on May 1, 2024 the Company granted inducement awards to purchase up to 100,600 shares of common stock to...
Today, U.S. Agency for International Development Administrator Samantha Power forged ahead in the fight against child malnutrition by announcing a $200 million investment in the procurement and distribution of Ready-to-Use Therapeutic Food (RUTF) ? a...